Everest Group PEAK Matrix®

Viedoc has been positioned as a Major Contender in Everest Group’s “Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment 2025.” 

Viedoc was recognized for its intuitive design, responsive customer support, and strong global reach. The report evaluated the vision, capabilities, and market impact of 19 eCOA platform providers based on customer case studies, revenue, key offerings, and recent progress. 

In the assessment, Viedoc distinguished itself through an intuitive and user-friendly interface, collaborative partnerships, and flexible commercial models that deliver strong value for sponsors and CROs. Buyers also highlighted Viedoc’s responsive support services and consultative approach, which help organizations simplify study setup and execution across regions and therapeutic areas. 

A key strength of Viedoc’s offering is the seamless integration of its eCOA and ePRO solution with Viedoc Clinic, the company's award-winning Electronic Data Capture (EDC) platform and recognized Leader in the EDC PEAK Matrix® Assessment 2024. By combining both within one ecosystem with a single design tool, Viedoc enables high market adoption while reducing the complexity of managing multiple systems, avoiding data silos, and ensuring a consistently strong user experience. This integration helps organizations achieve more efficient data flow and analysis, improving trial oversight and accelerating timelines. 

Everest Group on the eCOA market trends 

“The rising demand for real-time, patient-centric insights and low-code tools is fueling eCOA market momentum,” notes Everest Group in the report. Sponsors and sites increasingly require immediate access to patient-reported outcomes to monitor safety, track efficacy trends, and make timely adjustments. Intuitive, adaptable interfaces—like those offered by Viedoc—are critical for boosting patient engagement, ensuring compliance, and improving data accuracy.  

Everest Group on Viedoc’s eCOA strengths 

“Viedoc offers intuitive and user-friendly UI/UX and is recognized for its fair, flexible pricing models that clients see as strong value, along with timely support services. It is regarded as a strategic partner with a strong global presence, and its collaborative approach and expertise have contributed to its recognition as a Major Contender in Everest Group’s Life Sciences eCOA Products PEAK Matrix® Assessment 2025,” says Nisarg Shah, Practice Director at Everest Group. 

With recognition in both eCOA and EDC assessments, Viedoc is uniquely positioned to support sponsors and CROs with integrated, patient-centric clinical trial technology. 

About Everest Group

Everest Group is a leading global research firm helping business leaders make confident decisions. Everest Group's PEAK Matrix® assessments provide the analysis and insights enterprises need to make critical selection decisions about global services providers, locations, and products and solutions within various market segments. Likewise, providers of these services, products, and solutions, look to the PEAK Matrix® to gauge and calibrate their offerings against others in the industry or market. Find further details and in-depth content at  www.everestgrp.com.

Disclaimer
Licensed extracts taken from Everest Group’s PEAK Matrix® Reports, may be used by licensed third parties for use in their own marketing and promotional activities and collateral. Selected extracts from Everest Group’s PEAK Matrix® reports do not necessarily provide the full context of our research and analysis. All research and analysis conducted by Everest Group’s analysts and included in Everest Group’s PEAK Matrix® reports is independent and no organization has paid a fee to be featured or to influence their ranking. To access the complete research and to learn more about our methodology, please visit Everest Group PEAK Matrix® Reports.